EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic Epidemiology and Machine Learning–Based Drug Discovery for Antimicrobial Resistant Diarrheagenic Escherichia coli

Ayesha Masood, Fatima Noor, Abdu Rehman iD, Mohsin Gulzar Barq, Shazia Iqbal, Muhammad Qasim Ali, Shahzad Ahmad iD, Syed Zeeshan Haider Naqvi

MicrobiologyOpen · 2026-02 · 15 (1)

DOI: 10.1002/mbo3.70236 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MicrobiologyOpen, online erschienen am 22.02.2026. Verfasst von Ayesha Masood und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan. Hauptthemen laut MEDLINE: Machine Learning, Anti-Bacterial Agents, Escherichia coli Infections, Diarrhea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Buckingham, Buckingham, United Kingdom.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diarrheagenic Escherichia coli (DEC) is a leading cause of pediatric diarrhea, with antimicrobial resistance (AMR) complicating treatment. This study analyzed 350 E. coli isolates (175 DEC and 175 non‐DEC) to determine molecular pathotypes, resistance patterns, and therapeutic targets. Polymerase chain reaction and 16S ribosomal RNA sequencing identified enteropathogenic E. coli as the most prevalent DEC pathotype (35%), followed by enterotoxigenic E. coli (25%), enterohemorrhagic E. coli (15%), enteroinvasive E. coli (10%), and diffusely adherent E. coli (20%). Phylogenetic analysis confirmed distinct clustering between DEC and non‐DEC strains, revealing their evolutionary relationships. Antimicrobial susceptibility testing showed high resistance to ampicillin (87.6%), trimethoprim‐sulfamethoxazole (75.5%), and erythromycin (100%), while carbapenems and colistin retained effectiveness. Functional analysis using phylogenetic investigation of communities by reconstruction of unobserved states (PICRUSt) indicated enhanced metabolic and immune‐related functions in DEC strains, differentiating them from non‐DEC strains. Machine learning and bioinformatics‐driven drug discovery identified Alatamide and Isosativan as potential therapeutic compounds, exhibiting strong binding affinities and structural stability against DEC virulence targets through molecular docking and molecular dynamics simulations. This study provides critical insights into the epidemiology, genetic diversity, and resistance patterns of DEC and non‐DEC strains. The integration of bioinformatics and machine learning offers a promising strategy for discovering alternative treatments. Continuous AMR surveillance, responsible antibiotic use, and further experimental validation of identified drug candidates are essential to managing E. coli ‐associated diarrheal infections in pediatric populations and mitigating the global burden of multidrug‐resistant pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningAnti-Bacterial AgentsEscherichia coli InfectionsDiarrheaDrug DiscoveryEscherichia coliHumansMicrobial Sensitivity TestsPhylogenyMolecular EpidemiologyRNA, Ribosomal, 16SMolecular Docking SimulationDrug Resistance, BacterialDrug Resistance, Multiple, BacterialEnteropathogenic Escherichia coli

Stichwörter der Autor:innen

diarrheagenic Escherichia colimachine learningmolecular dockingmolecular dynamic simulationresistance

Substanzen

Anti-Bacterial AgentsRNA, Ribosomal, 16S

Autor:innen und Institutionen

  • Institute of Molecular Biology and Biotechnology (IMBB), The University of Lahore, Lahore, Pakistan.
  • Department of Pathology, University College of Medicine and Dentistry, The University of Lahore, Lahore, Pakistan.
  • Center of Bioinformatics, College of Life Sciences, Northwest Agriculture and Forestry University, Yangling, Shaanxi, China.
  • Department of Microbiology, University of Central Punjab (UCP), Lahore, Pakistan.
  • Faculty of Medicine and Health Sciences, The University of Buckingham, Buckingham, UK.
  • Microbiology Department of Gulab Devi Educational Complex, Lahore, Pakistan.

ORCID-Profile: Abdu Rehman, Shahzad Ahmad

Förderung

  • The University of Buckingham, Buckingham, United Kingdom

Zitieren

APA

Masood, A., Noor, F., Rehman, A., Barq, M. G., Iqbal, S., Ali, M. Q., Ahmad, S., & Naqvi, S. Z. H. (2026). Genomic Epidemiology and Machine Learning–Based Drug Discovery for Antimicrobial Resistant Diarrheagenic Escherichia coli. MicrobiologyOpen, 15(1). https://doi.org/10.1002/mbo3.70236

Vancouver

Masood A, Noor F, Rehman A, Barq MG, Iqbal S, Ali MQ, et al. Genomic Epidemiology and Machine Learning–Based Drug Discovery for Antimicrobial Resistant Diarrheagenic Escherichia coli. MicrobiologyOpen. 2026;15(1). doi:10.1002/mbo3.70236

BibTeX
@article{Masood2026,
  author = {Masood, Ayesha and Noor, Fatima and Rehman, Abdu and Barq, Mohsin Gulzar and Iqbal, Shazia and Ali, Muhammad Qasim and Ahmad, Shahzad and Naqvi, Syed Zeeshan Haider},
  title = {Genomic Epidemiology and Machine Learning–Based Drug Discovery for Antimicrobial Resistant Diarrheagenic Escherichia coli},
  journal = {MicrobiologyOpen},
  year = {2026},
  volume = {15},
  number = {1},
  doi = {10.1002/mbo3.70236}
}
Kostenlos starten →